After lung transplantation, recipients are regularly evaluated by the transplant team and often require multiple hospitalizations. The primary focus of care during this time is on detecting and treating complications and may not necessarily include advance care planning discussions. This focus may leave clinicians unaware of the recipient's treatment preferences and place a burden on families trying to decide whether to undergo or forgo life-sustaining treatment when the recipient's medical condition deteriorates. We report the case of a woman with bronchiolitis obliterans who was admitted to the transplant center 37 times and died in the intensive care unit. Although progressive deterioration of her medical condition was well documented, her medical records revealed no evidence of advance care planning discussions with the patient and family. Incorporating timely advance care planning and integrating palliative care in the ongoing posttransplant clinical management may benefit patients, families, and clinicians as recipients approach the final stage of their illness.
Get full access to this article
View all access options for this article.
References
1.
De Vito DabbsAJHoffmanLAIaconoA. Pattern and predictors of early allograft rejection after lung transplantation. Am J Crit Care.2003;12:497–507.
2.
ArcasoySMKotloffRM. Lung transplantation. N Engl J Med.1999;340:1081–1091.
3.
VermeulenKMGroenHvan der BijWErasmusMEKoeterGHTenVergertEM. The effect of bronchiolitis obliterans syndrome on health related quality of life. Clin Transplant.2004;18:377–383.
4.
GrossCRSavikKBolmanRM3rdHertzMI. Long-term health status and quality of life outcomes of lung transplant recipients. Chest.1995;108:1587–1593.
TrulockEPEdwardsLBTaylorDOBoucekMMKeckBMHertzMI. The Registry of the International Society for Heart and Lung Transplantation: Twenty-first official adult heart transplant report—2004. J Heart Lung Transplant.2004;23:804–815.
7.
LauCLPattersonGAPalmerSM. Critical care aspects of lung transplantation. J Intensive Care Med.2004;19:83–104.
8.
StuderSMLevyRDMcNeilKOrensJB. Lung transplant outcomes: A review of survival, graft function, physiology, health-related quality of life and cost-effectiveness. Eur Respir J.2004;24:674–685.
9.
SundaresanSTrulockEPMohanakumarTCooperJDPattersonGA. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Ann Thorac Surg.1995; 60:1341–1316; discussion 1346–1347.
10.
KshettryVRKroshusTJSavikKHertzMIBolmanRM. Primary pulmonary hypertension as a risk factor for the development of obliterative bronchiolitis in lung allograft recipients. Chest.1996;110:704–709.
11.
AdeDabbs VHoffmanLASwigartV. Striving for normalcy: Symptoms and the threat of rejection after lung transplantation. Soc Sci Med.2004;59:1473–1484.
12.
MishelMHMurdaughCL. Family adjustment to heart transplantation: Redesigning the dream. Nurs Res.1987;36:332–328.
13.
LevineSM. A survey of clinical practice of lung transplantation in North America. Chest.2004;125:1224–1238.
14.
ManzettiJDAnkenyRMillerD. Psychosocial and ethical issues in surgical approaches to end-stage lung disease. Clin Chest Med.1997;18:383–390.
15.
PersijnGGDe MeesterJM. Demand, supply and allocation in Eurotransplant. Ann Transplant.1997;2:26–33.
16.
GabbayEWilliamsTJGriffithsAP. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med.1999;160:265–271.
17.
SongMKKirchhoffKTDouglasJWardSHammesBJ. A randomized, controlled trial to improve advance care planning among patients undergoing cardiac surgery. Med Care.2005; 43:1049–1053.
18.
VerledenGMDupontLJVan RaemdonckDE. Is it bronchiolitis obliterans syndrome or is it chronic rejection: A reappraisal?Eur Respir J.2005;25:221–214.
19.
TrulockEPEdwardsLBTaylorDO. The Registry of the International Society for Heart and Lung Transplantation: Twentieth Official adult lung and heart-lung transplant report—2003. J Heart Lung Transplant.2003;22:625–635.
20.
TrulockEPEdwardsLBTaylorDOBoucekMMKeckBMHertzMI. Registry of the International Society for Heart and Lung Transplantation: Twenty-second official adult lung and heart-lung transplant report—2005. J Heart Lung Transplant.2005;24:956–967.
21.
CurtisJREngelbergRAWenrichMDShannonSETreecePDRubenfeldGD. Missed opportunities during family conferences about end-of-life care in the intensive care unit. Am J Respir Crit Care Med.2005;171:844–849.
22.
MossAH. A new clinical practice guideline on initiation and withdrawal of dialysis that makes explicit the role of palliative medicine. J Palliat Med.2000;3:253–260.
23.
GallaJH. Clinical practice guideline on shared decision-making in the appropriate initiation of and withdrawal from dialysis. Renal Physicians Association and the American Society of Nephrology. J Am Soc Nephrol.2000;11:1340–1342.
24.
HadjiliadisDSteeleMPGovertJADavisRDPalmerSM. Outcome of lung transplant patients admitted to the medical ICU. Chest.2004;125:1040–1045.
25.
FerrinMHappMBKaganSH. Palliative care and lung transplantation: Conflict or continuum?Am J Nurs.2001;101:61–66.
26.
LynnJGoldsteinNE. Advance care planning for fatal chronic illness: Avoiding commonplace errors and unwarranted suffering. Ann Intern Med.2003;138:812–818.
27.
Task Force on Palliative Care. Precepts of palliative care. J Palliat Med.1998;1:109–112.
